
Topic
Diabetes and Obesity
Metabolic drug access, GLP-1 and GIP/GLP-1 competition, obesity coverage, diabetes formularies, and payer restrictions.

Biosimilars· June 7, 2026 · 8 min read

Pricing & Access· June 6, 2026 · 14 min read
GLP-1 weight loss vs diabetes insurance coverage: how the indication changes everything
By Ran Chen#GLP-1#Prior Authorization#Weight Loss

Pricing & Access· June 6, 2026 · 12 min read
Medicare Part D GLP-1 coverage 2026: Bridge program, $2,100 cap, and indications
By Ran Chen#GLP-1#Medicare Part D#Prior Authorization

Pricing & Access· June 6, 2026 · 11 min read
VA GLP-1 coverage: formulary status, non-formulary Wegovy criteria, and CHAMPVA rules
By Ran Chen#GLP-1#Veterans Affairs#Prior Authorization

Biosimilars· May 27, 2026 · 11 min read
Lantus biosimilars and insulin glargine interchangeability guide

Pricing & Access· May 24, 2026 · 11 min read
SGLT2 inhibitor access landscape in 2026

Pricing & Access· May 23, 2026 · 9 min read
Trulicity coverage guide: formulary tiers, prior authorization, and patient assistance
By Ran Chen#GLP-1#Coverage Access#Prior Authorization